Diagnostic criteria of nonalcoholic fatty liver disease.
非酒精性脂肪性肝病诊断标准。
Nonalcoholic fatty liver disease (NAFLD) is a chronic illness with multiple consequences.
非酒精性脂肪性肝病(NAFLD)是一种慢性疾病，多种后果。
So, we know that 100% of nonalcoholic fatty liver disease patients have insulin resistance.
我们知道100%的非酒精性脂肪肝患者有胰岛素抵抗。
The FLD includes alcohol-induced liver disease (ALD) and nonalcoholic fatty liver disease (NAFLD).
临床上分为酒精性肝病（ALD）和非酒精性脂肪性肝病（NAFLD）两大类。
The prevalence of nonalcoholic fatty liver disease(NAFLD)has been increasing gradually year by year.
非乙醇性脂肪肝（ NAFLD）在临床上的发病率呈逐年上升趋势。
Left ventricular dysfunction in obese children and adolescents with nonalcoholic fatty liver disease.
【译】肥胖儿童非酒精性脂肪性肝病的青少年的左心室功能不全。
Nonalcoholic fatty liver disease (NAFLD) is one of the most common liver diseases in affluent countries.
在发达国家，非酒精性脂肪性肝病(NAFLD)是一种很常见的慢性肝脏疾病。
Objective To establish and evaluate the animal model of nonalcoholic fatty liver disease in Mongolian gerbils.
目的初步建立并评价蒙古沙鼠非酒精性脂肪性肝病模型。
Increased denovo lipogenesis is a distinct characteristic of individuals with nonalcoholic Fatty liver disease.
【译】增加从头脂肪生成与非酒精性脂肪肝的人的一个显著特点。
One of them is insulin resistance is a universal phenomenon in persons who have nonalcoholic fatty liver disease.
其中之一是胰岛素抵抗是非酒精性脂肪肝人群中很普遍的一个现象。
Whether this reflects nonalcoholic fatty liver disease or direct glycemic injury of the liver remains to be determined.
这是否反映了非酒精性脂肪性肝病或肝脏的直接血糖损伤，尚无法判断。
That is the fat that can cause all the complications of metabolic syndrome, including nonalcoholic fatty liver disease.
这种脂肪能引起代谢综合征相关并发症，包括非酒精性脂肪肝。
Objective To investigate the effects of "Qianggan Capsule" on hepatic lipid in nonalcoholic fatty liver disease (NAFLD) rats.
目的观察强肝胶囊对非酒精性脂肪肝(NAFLD)大鼠模型肝脏脂质的影响。
Cusi said nonalcoholic fatty liver disease probably accounts for about half of the people who develop cirrhosis of the liver.
Cusi认为非酒精性脂肪肝可能为约一半肝硬化患者的病因。
Objective: To observe the clinical effect and safety of Shugan Jiangzhuo Decoction in treating nonalcoholic fatty liver disease (NAFLD).
目的：观察疏肝降浊汤治疗非酒精性脂肪性肝病的临床疗效及安全性。
We know that 20% of those nonalcoholic fatty liver disease patients will go on to progress to a condition called NASH, which is nonalcoholic Steatohepatitis.
而20%的非酒精性脂肪肝的患者会进展为非酒精性脂肪型肝炎(简称NASH)。
Objective to investigate the relationship between metabolic syndrome (MS) and nonalcoholic fatty liver disease (NAFLD) in non-obese impaired glucose tolerant (IGT) subjects.
目的探讨非肥胖的糖耐量受损(igt)者的非酒精性脂肪性肝病(NAFLD)与代谢综合征(MS)的关系。
Effect of Fenofibrate and Niacin on Intrahepatic Triglyceride Content, Very Low-Density Lipoprotein Kinetics, and Insulin Action in Obese Subjects with Nonalcoholic Fatty Liver Disease.
非诺贝特和烟酸对非酒精脂肪肝患者肝内甘油三酯含量，极低密度脂蛋白动力学，胰岛素活性的影响。
Patients with nonalcoholic fatty liver disease (NAFLD) have suboptimal levels of cardiovascular fitness, muscle strength, body composition and physical fitness, according to a new study.
根据一项新的研究显示，非酒精性脂肪肝（NAFLD）患者的心血管顺应性，肌力，机体组成和体能都低于最适水平。
Nonalcoholic fatty liver disease (NAFLD) has been consistently found to be associated with features of the metabolic syndrome (MS), a condition carrying a high risk of cardiovascular events.
研究表明，脂肪性肝病使血管壁从解剖学和功能上都发生了较大改变，检测该病对筛查高风险心血管疾病患儿有极为重要的临床意义。
So, not only it's important to focus on treatment of nonalcoholic fatty liver disease by itself because it is an important liver disease, but also it can aggravate other type of liver disease.
因此，我们不仅要重视治疗非酒精性脂肪肝本身，因为它本身是重要的一种肝病，而且它能使其他疾病恶化。
Nonalcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease among people who don't drink alcohol, and your risk for developing the condition increases along with your weight.
非酒精性脂肪肝病(NAFLD)是一种常见的慢性肝病，患者大都不喝酒，并且发病的概率与患者的体重成正比。
Nonalcoholic fatty liver disease(NAFLD) is a kind of chronic liver disease, whose spectrum of the disease includes simple hepar adiposum, steatohepatitis(NASH), hepatic fibrosis, and cirrhosis.
非乙醇性脂肪性肝病（NAFLD）是一种常见的慢性肝病，其疾病谱包括单纯性脂肪肝、非乙醇性脂肪性肝炎（NASH）、肝纤维化及肝硬化。
Objective To investigate the effect of rosiglitazone and reduced glutathione on insulin signaling proteins in rats with nonalcoholic fatty liver disease(NAFLD). Methods NAFLD rats were produced.
目的研究罗格列酮联合还原型谷胱甘肽对非酒精性脂肪性肝病（NAFLD）大鼠胰岛素以及胰岛素信号转导相关蛋白表达的影响。
Fatty liver disease can take many forms that vary in severity, with the most severe being nonalcoholic steatohepatitis (NASH), fibrosis and cirrhosis. NAFLD can lead to liver failure.
脂肪性肝病恶化后会很复杂，最严重的是非酒精性脂肪肝炎、肝纤维化、肝硬化。非酒精性脂肪肝会导致肝功能衰竭。
Fatty liver disease can take many forms that vary in severity, with the most severe being nonalcoholic steatohepatitis (NASH), fibrosis and cirrhosis.
脂肪性肝病恶化后会很复杂，最严重的是非酒精性脂肪肝炎、肝纤维化、肝硬化。
Nonalcoholic fatty liver is a kind of disease related to heredity, environment, and metabolism instead of alcohol. It is a major factor increasing the morbidity or mortality of liver-related disease.
非酒精性脂肪肝是一种无过量饮酒史，与遗传-环境-代谢应激相关性疾病，导致肝相关性患病率和病死率升高的主要原因之一。
Nonalcoholic fatty liver is a kind of disease related to heredity, environment, and metabolism instead of alcohol. It is a major factor increasing the morbidity or mortality of liver-related disease.
非酒精性脂肪肝是一种无过量饮酒史，与遗传-环境-代谢应激相关性疾病，导致肝相关性患病率和病死率升高的主要原因之一。
应用推荐